Immix Biopharma | Investor Presentation Deck | 57 slides · page 8 of 57
The slide highlights the structural difference of the NXC-201 molecule compared to Abecma, Carvykti, and CART-ddBCMA.
Pitch deck · unfair_advantage · present_solution · sparse density
Slide locked Sign in to view
Slide schematic 3/3
image 1/1 source-note 1/1 title 1/1
Components 3
illustration source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.